60 results
Page 2 of 3
6-K
EX-99.1
ndcr8myzsz1kuht5ya
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
6-K
EX-1.1
xupjp3 eicdbshr
19 Apr 22
Open Market Sale Agreementsm
4:05pm
424B5
5pci6u6fivlon56p
19 Apr 22
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
u6j46nnhe67pvfhep
14 Apr 22
Notice of Annual Meeting of Shareholders
4:45pm
F-3
EX-5.1
vslmpm 2xu
7 Apr 22
Shelf registration (foreign)
5:30pm
20-F/A
x210mxiq0h czcjse2k
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.1
iuhwks82 43i09xj1hiy
30 Mar 22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
7:53am
6-K
EX-99.1
mwy7njgr
5 Jan 22
Current report (foreign)
9:03am
6-K
EX-99.1
sxjpco5h 114
16 Nov 21
Current report (foreign)
4:05pm
6-K
EX-99.1
pek68u15 bnce
12 Nov 21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
12:00am
6-K
EX-99.1
kus505n
9 Sep 21
Current report (foreign)
11:29am
6-K
EX-99.1
pvtxp
4 Aug 21
Current report (foreign)
7:17am
6-K
EX-99.1
uk64wu
4 Aug 21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights
7:16am
6-K
EX-99.1
8sikvr16dbv1ojn wb3g
28 Jun 21
Current report (foreign)
8:16am
6-K
EX-99.1
f131ciq
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am